NFKB1 and type 2 diabetes mellitus: In T2D, RAAS activity is amplified and evidence suggests that angiotensin-2, a mediator in the RAAS pathway, can activate NF-κB resulting in myocardial inflammation (Sciarretta et al., 2009).